Vymada 100 MG Tab

Composition

Sacubitril 49 mg + Valsartan 51 mg (as sacubitril/valsartan) per tablet

Uses of Vymada 100 MG Tab

Treatment of chronic heart failure with reduced ejection fraction (HFrEF) to reduce the risk of cardiovascular death and hospitalization for heart failure; used in place of an ACE inhibitor or ARB as advised by doctor.

• •Reduces risk of hospitalization in HFrEF
• •Lowers cardiovascular death risk in HFrEF
• •Improves symptoms and exercise tolerance in heart failure
• •Helps reduce cardiac workload and blood pressure

How it works

Sacubitril inhibits neprilysin, increasing levels of beneficial natriuretic peptides that promote vasodilation and sodium excretion. Valsartan blocks angiotensin II (AT1) receptors, reducing vasoconstriction and aldosterone effects. Together they lower cardiac workload and improve heart failure outcomes.

Directions for use

Oral tablet. Take exactly as prescribed, usually twice daily. Can be taken with or without food; take at the same times each day. Do not start within 36 hours of stopping an ACE inhibitor; do not stop or change dose without medical advice.

Side effects

Common side effects of Vymada 100 MG Tab may include:

• •Low blood pressure (dizziness)
• •increased potassium (hyperkalemia)
• •kidney function changes
• •